AbbVie
Venture capital · North Chicago, Illinois, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio1 active
5Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Harpoon Therapeutics
6Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| DISCO Pharmaceuticals | Biotech | Active | — | — |
| Harpoon Therapeutics | Biotech | Acquired | Oct 31, 2023 | $220.3M |
| Aliada Therapeutics | Biotech | Acquired | Dec 30, 2022 | $33.0M |
| Landos Biopharma | Biotech | Acquired | Aug 23, 2019 | $60.3M |
| Cerevel Therapeutics | Biotech | Acquired | — | — |
| ImmunoGen | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#40
Raises, 12 months#88
Co-investors#188
Co-investors
- Amgen VenturesVenture capital1 shared
- Blackstone Life SciencesVenture capital1 shared
- MedImmune VenturesVenture capital1 shared
- MRL Ventures FundVenture capital1 shared
- RA CapitalVenture capital1 shared
- XontogenyVenture capital1 shared
Sectors
- Biotech6
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.